Company Overview
RELAY THERAPEUTICS, INC.
RLAYRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
15M
2025 FY
Net Income
-276M
2025 FY
Shares Outstanding
172M
2025 FY
EPS
-1.61USD
2025 FY
Company Information
SIC Code
2836
CIK Code
1812364
Exchange
Nasdaq
Location
US